AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Case Report | Open Access

Neuronal intranuclear inclusion disease with sudden visual impairment

Lili Liu1Juanjuan Chen1Zhijian LinJun HuYunong Li( )Fenli Zhou( )
Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China

1 Lili Liu and Juanjuan Chen have contributed equally to this work.

Show Author Information

Abstract

Here we report a case of a 67-year-old female patient who presented with headache, limb tremors, and acute complete vision loss. Physical examination revealed bilateral miosis, and diffusion-weighted imaging sequences showed mild diffusion restriction in the subcortical regions of both occipital lobes. Genetic results revealed 85 GGC repeats in the 5′-untranslated region of the NOTCH2NLC gene. The therapeutic effect of dexamethasone and acyclovir was minimal. NIID must be considered in patients with acute onset and various clinical manifestations and imaging findings similar to encephalitis. We hope that our case presentation will enhance clinicians’ awareness of NIID.

Electronic Supplementary Material

Download File(s)
jnrt-13-3-100193_ESM.docx (5.8 MB)

References

1

Sone J, Mori K, Inagaki T, et al. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016;139(Pt 12):3170–3186. https://doi.org/10.1093/brain/aww249.

2

Lindenberg R, Rubinstein LJ, Herman MM, et al. A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol. 1968;10(1):54–73. https://doi.org/10.1007/BF00690510.

3

Sone J, Tanaka F, Koike H, et al. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology. 2011;76(16):1372–1376. https://doi.org/10.1212/WNL.0b13e3182166e13.

4

Ishiura H, Shibata S, Yoshimura J, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019;51(8):1222–1232. https://doi.org/10.1038/s41588-019-0458-z.

5

Deng JW, Gu ML, Miao Y, et al. Long-read sequencing identified repeat expansions in the 5'UTR of the NOTCH2NLC gene from Chinese patients with neuronal intranuclear inclusion disease. J Med Genet. 2019;56(11):758–764. https://doi.org/10.1136/jmedgenet-2019-106268.

6

Sone J, Mitsuhashi S, Fujita A, et al. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 2019;51(8):1215–1221. https://doi.org/10.1038/s41588-019-0459-y.

7

Tian Y, Wang JL, Huang W, et al. Expansion of human-specific GGC repeat in neuronal intranuclear inclusion disease-related disorders. Am J Hum Genet. 2019;105(1):166–176. https://doi.org/10.1016/j.ajhg.2019.05.013.

8

Chen LL, Wu L, Li SH, et al. A long time radiological follow-up of neuronal intranuclear inclusion disease: two case reports. Medicine. 2018;97(49):e13544. https://doi.org/10.1097/MD.0000000000013544.

9

Jiao B, Zhou L, Zhou YF, et al. Identification of expanded repeats in NOTCH2NLC in neurodegenerative dementias. Neurobiol Aging. 2020;89:142.e1–142.e7. https://doi.org/10.1016/j.neurobiolaging.2020.01.010.

10

Chen H, Lu LK, Wang B, et al. Re-defining the clinicopathological spectrum of neuronal intranuclear inclusion disease. Ann Clin Transl Neurol. 2020;7(10):1930–1941. https://doi.org/10.1002/acn3.51189.

11

Lu X, Hong DJ. Neuronal intranuclear inclusion disease: recognition and update. J Neural Transm. 2021;128(3):295–303. https://doi.org/10.1007/s702-021-02313-3.

12

Nakamura M, Ueki S, Kubo M, et al. Two cases of sporadic adult-onset neuronal intranuclear inclusion disease preceded by urinary disturbance for many years. J Neurol Sci. 2018;392:89–93. https://doi.org/10.1016/j.jns.2018.07.012.

13

Wang Y, Wang B, Wang L, et al. Diagnostic indicators for adult-onset neuronal intranuclear inclusion disease. Clin Neuropathol. 2020;39(1):7–18. https://doi.org/10.5414/NP301203.

14

Sui YH, Shi Y, Yang YM, et al. Neuronal intranuclear inclusion disease: a case report and literature review. Acta Neurol Belg. 2023;123(4):1651–1653. https://doi.org/10.1007/s13760-023-02210-4.

15

Haltia M, Tarkkanen A, Somer H, et al. Neuronal intranuclear inclusion disease. Clinical ophthalmological features and ophthalmic pathology. Acta Ophthalmol. 1986;64(6):637–643.

16

Omoto S, Hayashi T, Matsuno H, et al. Neuronal intranuclear hyaline inclusion disease presenting with childhood-onset night blindness associated with progressive retinal dystrophy. J Neurol Sci. 2018;388:84–86. https://doi.org/10.1016/j.jns.2018.03.010.

17

Yamada W, Takekoshi A, Ishida K, et al. Case of adult-onset neuronal intranuclear hyaline inclusion disease with negative electroretinogram. Doc Ophthalmol. 2017;134(3):221–226. https://doi.org/10.1007/s10633-017-9584-z.

18

Chen ZB, Yau WY, Jaunmuktane Z, et al. Neuronal intranuclear inclusion disease is genetically heterogeneous. Ann Clin Transl Neurol. 2020;7(9):1716–1725. https://doi.org/10.1002/acn3.51151.

19

Tai HF, Wang A, Zhang YM, et al. Clinical features and classification of neuronal intranuclear inclusion disease. Neurol Genet. 2023;9(2):e200057. https://doi.org/10.1212/NXG.0000000000200057.

20

Feng CY, Chen Q, Luan XH, et al. Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series. Front Med. 2024;11:1188193. https://doi.org/10.3389/fmed.2024.1188193.

21

Nakamura N, Tsunoda K, Mitsutake A, et al. Clinical characteristics of neuronal intranuclear inclusion disease-related retinopathy with CGG repeat expansions in the NOTCH2NLC gene. Investig Ophthalmol Vis Sci. 2020;61(11):27. https://doi.org/10.1167/iovs.61.11.27.

22

Liu C, Luan XH, Liu XH, et al. Characteristics of ocular findings of patients with neuronal intranuclear inclusion disease. Neurol Sci. 2022;43(5):3231–3237. https://doi.org/10.1007/s10072-021-05748-4.

23

Lee GH, Jung E, Jung NY, et al. Case report: neuronal intranuclear inclusion disease initially mimicking reversible cerebral vasoconstriction syndrome: serial neuroimaging findings during an 11-year follow-up. Front Neurol. 2024;15:1347646. https://doi.org/10.3389/fneur.2024.1347646.

24

Yoshii D, Ayaki T, Wada T, et al. An autopsy case of adult-onset neuronal intranuclear inclusion disease with perivascular preservation in cerebral white matter. Neuropathology. 2022;42(1):66–73. https://doi.org/10.1111/neup.12778.

25

Kutsuna F, Tateishi Y, Yamashita K, et al. Perfusion abnormality in neuronal intranuclear inclusion disease with stroke-like episode: a case report. Cereb Circ Cogn Behav. 2022;3:100127. https://doi.org/10.1016/j.cccb.2022.100127.

26

Sone J, Kitagawa N, Sugawara E, et al. Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry. 2014;85(3):354–356. https://doi.org/10.1136/jnnp-2013-306084.

27

Zhang GJ, Wu D, Zhu YX, et al. Clinicopathological features of neuronal intranuclear inclusion disease diagnosed by skin biopsy. Neurol Sci. 2022;43(3):1809–1815. https://doi.org/10.1007/s10072-021-05526-2.

28

Kawarabayashi T, Nakamura T, Seino Y, et al. Disappearance of MRI imaging signals in a patient with neuronal intranuclear inclusion disease. J Neurol Sci. 2018;388:1–3. https://doi.org/10.1016/j.jns.2018.02.038.

29

Okubo M, Doi H, Fukai R, et al. GGC repeat expansion of NOTCH2NLC in adult patients with leukoencephalopathy. Ann Neurol. 2019;86(6):962–968. https://doi.org/10.1002/ana.25586.

30

Liu YQ, Li H, Liu X, et al. Clinical and mechanism advances of neuronal intranuclear inclusion disease. Front Aging Neurosci. 2022;14:934725. https://doi.org/10.3389/fnagi.2022.934725.

31

Deng JW, Zhou BB, Yu JX, et al. Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion disease. J Med Genet. 2022;59(5):462–469. https://doi.org/10.1136/jmedgenet-2020-107649.

32

Bao L, Zuo DD, Li QJ, et al. Current advances in neuronal intranuclear inclusion disease. Neurol Sci. 2023;44(6):1881–1889. https://doi.org/10.1007/s10072-023-06677-0.

33

Fang P, Yu YY, Yao S, et al. Repeat expansion scanning of the NOTCH2NLC gene in patients with multiple system atrophy. Ann Clin Transl Neurol. 2020;7(4):517–526. https://doi.org/10.1002/acn3.51021.

34

Ma DR, Tan YJ, Ng ASL, et al. Association of NOTCH2NLC repeat expansions with Parkinson disease. JAMA Neurol. 2020;77(12):1559–1563. https://doi.org/10.1001/jamaneurol.2020.3023.

35

Ogasawara M, Iida A, Kumutpongpanich T, et al. CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun. 2020;8(1):204. https://doi.org/10.1186/s40478-020-01084-4.

36

Yuan YC, Liu Z, Hou X, et al. Identification of GGC repeat expansion in the NOTCH2NLC gene in amyotrophic lateral sclerosis. Neurology. 2020;95(24):e3394–e3405. https://doi.org/10.1212/WNL.0000000000010945.

37

Westenberger A, Klein C. Essential phenotypes of NOTCH2NLC-related repeat expansion disorder. Brain. 2020;143(1):5–8. https://doi.org/10.1093/brain/awz404.

38

Krzyzosiak WJ, Sobczak K, Wojciechowska M, et al. Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res. 2012;40(1):11–26. https://doi.org/10.1093/nar/gkr729.

39

Rebecca Glineburg M, Todd PK, Charlet-Berguerand N, et al. Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome. Brain Res. 2018;1693(Pt A):43–54. https://doi.org/10.1016/j.brainres.2018.02.006.

40

Boivin M, Charlet-Berguerand N. Trinucleotide CGG repeat diseases: an expanding field of polyglycine proteins? Front Genet. 2022;13:843014. https://doi.org/10.3389/fgene.2022.843014.

41

Zhong SP, Lian YY, Luo WY, et al. Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases. Acta Neuropathol. 2021;142(6):1003–1023. https://doi.org/10.1007/s401-021-02375-3.

42

Liu Q, Zhang KL, Kang Y, et al. Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease. Sci Adv. 2022;8(47):eadd6391. https://doi.org/10.1126/sciadv.add6391.

43

Liu YH, Chou YT, Chang FP, et al. Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy. Brain. 2022;145(9):3010–3021. https://doi.org/10.1093/brain/awac135.

Journal of Neurorestoratology
Cite this article:
Liu L, Chen J, Lin Z, et al. Neuronal intranuclear inclusion disease with sudden visual impairment. Journal of Neurorestoratology, 2025, 13(3). https://doi.org/10.1016/j.jnrt.2025.100193

44

Views

0

Crossref

0

Web of Science

0

Scopus

Altmetrics

Received: 01 September 2024
Revised: 06 December 2024
Accepted: 18 January 2025
Published: 01 June 2025
© 2025 The Author(s).

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return